View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
February 25, 2021

Medical Devices industry venture financing deals total $936.83m in North America in January 2021

Total medical devices industry venture financing deals worth $936.83m were announced in North America in January 2021, led by $190m venture financing of Valo Health, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 2.9% over the previous month of $910.37m and a rise of 13.2% when compared with the last 12-month average of $827.43m.

North America held an 82.18% share of the global medical devices industry venture financing deal value that totalled $1.14bn in January 2021. With an 81.52% share and deals worth $929.33m, the US was the top country in North America’s venture financing deal value across medical devices industry.

In terms of venture financing deal activity, North America recorded 27 deals during January 2021, marking a decrease of 42.55% over the previous month and a drop of 52.63% over the 12-month average. The US recorded 24 deals during the month.

North America medical devices industry venture financing deals in January 2021: Top deals

The top five medical devices industry venture financing deals accounted for 68.5% of the overall value during January 2021.

The combined value of the top five medical devices venture financing deals stood at $642m, against the overall value of $936.83m recorded for the month.

The top five medical devices industry venture financing deals of January 2021 tracked by GlobalData were:

1) Atinum Investment, HBM Healthcare Investments, Invus Public Equities, Mirae Asset Capital and Public Sector Pension Investment Board’s $190m venture financing of Valo Health

2) The $167m venture financing of Color Genomics by General Catalyst Partners, T Rowe Price Associates and Viking Global Investors

3) AV8 Ventures, Cowen Healthcare Investments, Foresite Capital Management, Illumina Ventures, Menlo Ventures, Northpond Ventures, Orbimed Advisors, Osage University Partners, Rock Springs Capital Management, Samsara BioCapital, T Rowe Price Associates and Windham Venture Partners’ $100m venture financing of Delfi Diagnostics

4) The $100m venture financing of SPaige.AI by Casdin Capital and Johnson & Johnson Innovation – JJDC

5) Ally Bridge Group and Perceptive Advisors’ venture financing of IsoPlexis for $85m.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network